Evidence map›Paper›PMID 35125112›Full record

ArticleLipids in health and disease2022

Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes.

Shelby M Flaherty, Elizabeth K Wood, Carol D Ryff, Gayle D Love, Theodoros Kelesidis, Loni Berkowitz, Guadalupe Echeverría, Katherine Rivera, Attilio Rigotti, Christopher L Coe

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  4. Review
  5. Article
  6. Article
  7. The Association of HDL2b with Metabolic Syndrome Among Normal HDL-C Populations in Southern China.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Shelby M FlahertyHarlow Center for Biological Psychology, University of Wisconsin-Madison, Madison, WI, USA.
Elizabeth K WoodOregon Health and Science University, Portland, OR, USA.
Carol D RyffInstitute on Aging, University of Wisconsin-Madison, Madison, WI, USA.
Gayle D LoveInstitute on Aging, University of Wisconsin-Madison, Madison, WI, USA.
Theodoros KelesidisDepartment of Medicine, University of California, Los Angeles, CA, USA.
Loni BerkowitzDepartamento de Nutrición, Diabetes y Metabolismo; Escuela de Medicina, Pontificia Universidad Católica, Santiago, Chile.
Guadalupe EcheverríaDepartamento de Nutrición, Diabetes y Metabolismo; Escuela de Medicina, Pontificia Universidad Católica, Santiago, Chile.
Katherine RiveraDepartamento de Nutrición, Diabetes y Metabolismo; Escuela de Medicina, Pontificia Universidad Católica, Santiago, Chile.
Attilio RigottiDepartamento de Nutrición, Diabetes y Metabolismo; Escuela de Medicina, Pontificia Universidad Católica, Santiago, Chile.
Christopher L CoeHarlow Center for Biological Psychology, University of Wisconsin-Madison, Madison, WI, USA. ccoe@wisc.edu.ORCID http://orcid.org/0000-0001-9335-9060
Pontificia Universidad Católica de Chile · CLUniversity of Wisconsin–Madison · USOregon Health & Science University · USUniversity of California, Los Angeles · US

Funding

U19 MIDlife in the United States-Diversity Supplement-WellsU19AG051426 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI CAROL D. RYFF · 2016 to 2026
$74.8M
A Feasibility Study to Improve Older Patient - Physician CommunicationR21AG030166 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAALEMAN, TIMOTHY P. · 2009 to 2010
$334k
NIA NIH HHS P01 AG030166NIA NIH HHS R21 AG030166NIA NIH HHS U19 AG051426
6 · The paper itself

Abstract

backgroundHigh-density lipoprotein (HDL) plays a critical role in protection against atherosclerosic and cardiovascular disease (ASCVD). In addition to contributing to clearing excess vascular cholesterol, HDL particles exhibit antioxidative functions, helping to attenuate adverse effects of oxidized low-density lipoproteins. However, these beneficial properties can be undermined by oxidative stress, inflammation, and unhealthy lifestyles and diet, as well as influenced by race and sex. Thus, when assessing cardiovascular risk, it is important to consider multifactorial aspects of HDL, including antioxidant activity rather than just total amount and type of HDL-cholesterol (HDL-C) particles. Because prior research showed HDL peroxide content (HDLperox) can be inversely associated with normal anti-oxidant HDL activity, elevated HDLperox may serve as a bioindicator of HDL dysfunction.

methodsIn this study, data from a large national cohort of Americans was utilized to determine the impact of sex, race, and diabetes status on HDLperox in middle-aged and older adults. A previously developed cell-free fluorometric method was utilized to quantify HDLperox in serum depleted of apo-B containing lipoproteins.

resultsIn keeping with predictions, white men and diabetics exhibited HDLperox in the atypical upper range, suggestive of less functional HDL. White men had higher HDLperox levels than African American males (13.46 ± 6.10 vs. 10.88 ± 5.81, p < .001). There was also a significant main effect of type 2 diabetes (F(1,1901) = 14.9, p < .0001). Overall, African Americans evinced lower HDLperox levels, despite more obesity (10.3 ± 4.7 vs.11.81 ± 5.66 for Whites) suggesting that other aspects of lipid metabolism and psychosocial factors account for the higher prevalence of ASCVD in African Americans.

conclusionThis research helps to provide a more comprehensive understanding of HDL function in a racially and metabolically diverse adult population. HDLperox content was significantly different in adults with type 2 diabetes, and distinctive in nondiabetic White males, and suggests other processes account for the higher prevalence of ASCVD among African Americans.

Indexed as

Black or African AmericanCase-Control StudiesCholesterol, HDLDiabetes Mellitus, Type 2FemaleHumansLipid PeroxidesMaleMiddle AgedRacial GroupsSex FactorsUnited StatesWhite PeopleCholesterol, HDLLipid PeroxidesCholesterolDiabetesDyslipidemia lipid peroxidationHDL functionObesityRace

Identifiers

PMID35125112
PMCPMC8818198
OpenAlexW4210254593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.